Evogliptin tartrate is a dipeptidyl peptidase IV inhibitor, in tablet form. Evogliptin tartrate tablets is expected to be approved for the treatment of type 2 diabetes mellitus. Reference standards of Evogliptin Tartrate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Evogliptin Tartrate
Catalogue No.:PA 05 66000
CAS :
Molecular Formula : C23H32F3N3O9
Molecular Weight : 551.51
Evogliptin Tartrate Impurity S1
Catalogue No.:PA 05 66510
Evogliptin Tartrate Impurity S2
Catalogue No.:PA 05 66520
Evogliptin Tartrate Impurity S3
Catalogue No.:PA 05 66530
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
